Contact us for free information or to start a free case review.
In March 2003, Public Citizen consumer group petitioned the FDA for a Serzone withdrawal action. The consumer group noted in the petition for the Serzone withdrawal that a European Serzone withdrawal has already occurred due to the serious and deadly adverse reaction reported in Serzone patients. Since 1998, Serzone liver toxicity concerns have been associated to the drug and the consumer group has found “no justification for continuing to market this dangerous drug” based on the ongoing evidence that has led some countries to issue a Serzone withdrawal.
Serzone has also failed to show any increased efficacy than older antidepressants, though over 4.5 million prescriptions a year are written for Serzone. The failure of the FDA to issue a Serzone withdrawal despite the at least 53 cases of liver injury that includes 21 cases of liver failure resulting in 11 deaths has left the watchdog group representing 125,000 consumers nationwide to question why the U.S. is behind other countries in implementing the Serzone withdrawal. The U.S. has allowed Serzone to remain on the market while endangering a potentially high amount of Serzone patients, yet other countries have found there is enough evidence and adverse events reports to justify a Serzone withdrawal.
Drug manufacturer Bristol-Meyers announced Wednesday that it will no longer make or sell Serzone, an antidepressant that has been linked to potentially deadly liver complications and has already been withdrawn in major markets including Europe and Can...
Public Citizen has sued the FDA, calling the agency "grossly negligent" for failing to issue a Serzone ban despite having already been taken off the market in Canada and Europe, with sales to end in Australia and New Zealand in May. The consumer watchd...
Copyright © 2001 - 2012 Online Lawyer Source | Legal Marketing Site Designed by eJustice
ATTORNEY ADVERTISEMENT—Thank you for your visit. The content published on this website was not written by medical professionals and should not, at any point, be mistaken for medical advice. Furthermore, the information on this site is intended for educational purposes only and should never interfere with a patient/site visitor and his or her healthcare provider. In addition, viewing the content on this website, requesting additional information, or transmitting information through a contact form should never be considered the formation of an attorney-client relationship. The material published on this site is general and may not apply to your specific circumstances. Every case comes with its own set of unique circumstances; past success discussed on this site does not guarantee future performance. Information found on this website should not be used as incentive to act without seeking counsel from a professional. For more information, please read our disclaimer.